BEGIN:VCALENDAR VERSION:2.0 PRODID:icalendar-ruby CALSCALE:GREGORIAN BEGIN:VEVENT DTSTAMP:20240329T124653Z UID:94d48706-1bb2-4975-ab79-b031cb72de80 DTSTART:20210503T080000 DTEND:20210504T080000 CLASS:PRIVATE DESCRIPTION:
Gene Therapy for Rare Disorders \;focus es exclusively on overcoming the late-stage commercial challenges drug dev elopers face when delivering gene therapies to market.
\n\nIncorpora ting insights from \;Spark\, FDA\, Bluebird Bio\, Pfizer \ ;and \;GSK\,this unique conference delves in to the key \;regulatory\, reimbursement\, clinical and manufac turing \;hurdles that need to be overcome to realize the comm ercial potential of gene therapies.
\n\nJoin 250+ of your colleagues
to accelerate the progress of the next generation of gene therapies that
show improved efficacy\, enhanced safety and commercial viability.
\n
\n
\nJOA180515CEV